Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Development and optimization of topical cyclosporin liposomal gel (2% w/w): double-blind, placebo-controlled clinical trial for efficacy and safety evaluation in patients with stable plaque psoriasis

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: KHURANA, Rajiv Kumar (University Institute of Pharmaceutical Sciences-Panjab University, Chandigarh, India)
  • Co-author(s): Dogra, Sunil (Dept. of Dermatology, Post-Graduate Institute of Medical Research, Chandigarh, India)
    Kaur, Inderjeet (Dept of Dermatology, Post-Graduate Institute of Medical Research, Chandigarh, India)
    Bhoop, Bhupinder Singh (University Institute of Pharmaceutical Sciences-Panjab University, CHANDIGARH, India)
    Katare, Om Prakash (University Institute of Pharmaceutical Sciences-Panjab University, CHANDIGARH, India)
  • Abstract:

    Topical delivery of Cyclosporin A (CysA) is highly desirable for various dermatological diseases including psoriasis. However the horny stratum corneum barrier and the unfavorable physicochemical properties of CysA are the major hicupps.(1) Phospholipid-structured liposomes have been successfully used for cutaneous delivery of several therapeutic..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses